Stock Events

Stock Events

AMGEN 

€338.60
3917
-€19.60-5.47% 06:04 Today

Statistics

Day High
338.6
Day Low
338.6
52W High
382.45
52W Low
230.75
Volume
0
Avg. Volume
8
Mkt Cap
183.06B
P/E Ratio
-
Dividend Yield
2.42%
Dividend
8.19

Upcoming

Dividends

2.42%Dividend Yield
Sep 26
€2.17
Jun 26
€2.19
Mar 26
€2.17
Dec 25
€2.03
Sep 25
€2.03
10Y Growth
10.07%
5Y Growth
8.44%
3Y Growth
2.68%
1Y Growth
-0.41%

Earnings

3NovExpected
Q4 2025
Q1 2026
Q2 2026
Next
4.01
4.49
4.97
5.45
Expected EPS
4.9761616466100005
Actual EPS
N/A

Financials

20.99%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
31.87BRevenue
6.69BNet Income

Analyst Ratings

305.65Average Price Target
The highest estimate is 349.05.
From 16 ratings within the last 6 months. This is not an investment recommendation.
Buy
31%
Hold
69%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AMG.MU. It's not an investment recommendation.
Abbvie
946
ABBV
Microsoft
864
MSFT
Apple
827
AAPL
Realty Income
776
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap187.23B
Gilead Sciences competes in the biopharmaceutical sector focusing on antiviral drugs, similar therapeutic areas as Amgen.
Abbvie
ABBV
Mkt Cap453.19B
AbbVie operates in the same biopharmaceutical space, with a strong presence in immunology and oncology, directly competing with Amgen's product lines.
Bristol-Myers Squibb
BMY
Mkt Cap136.49B
Bristol Myers Squibb is a major player in the biopharmaceutical industry, with a focus on cancer and immune system disorders, overlapping with Amgen's market.
Pfizer
PFE
Mkt Cap162.16B
Pfizer is a global pharmaceutical company with a broad range of products that compete across several of Amgen's key therapeutic areas.
Merck
MRK
Mkt Cap370.89B
Merck & Co. focuses on pharmaceuticals including oncology, vaccines, and animal health, competing with Amgen in the oncology and biologic drugs market.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson, through its pharmaceutical division Janssen, competes in the immunology and oncology sectors, similar to Amgen.
Regeneron Pharmaceuticals
REGN
Mkt Cap85.22B
Regeneron Pharmaceuticals specializes in biopharmaceuticals, particularly in monoclonal antibodies, a direct competitor to Amgen's biologic treatments.
Novartis
NVS
Mkt Cap304.1B
Novartis is a global healthcare company that competes with Amgen in several areas, including biopharmaceuticals and generic drugs.
Rogers
ROG
Mkt Cap2.28B
Roche Holding AG, with its strong focus on oncology and immunotherapy, competes directly with Amgen in the biopharmaceutical and diagnostics sectors.
Sanofi
SNY
Mkt Cap106.01B
Sanofi operates globally in the pharmaceutical sector, with a focus on diabetes, oncology, and rare diseases, areas where Amgen also has significant interests.

About

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis, which has been further strengthened with the launch of new drugs in blood cancers (Blincyto) and solid tumors (Imdelltra). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
Show more...
CEO
Robert A. Bradway
Employees
31500
Country
United States
ISIN
US0311621009
WKN
000867900

Listings

XNAS
US
AMGN
F
DE
AMG0.F
STU
DE
AMG.STU
SN
CL
AMGN.SN

0 Comments

Share your thoughts

FAQ

What is AMGEN stock price today?▼
The current price of AMG.MU is €338.60 EUR — it has decreased by -5.47% in the past 24 hours. Watch AMGEN stock price performance more closely on the chart.
What is AMGEN stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange AMGEN stocks are traded under the ticker AMG.MU.
Is AMGEN stock price growing?▼
AMG.MU stock has fallen by -10.57% compared to the previous week, the month change is a -2.45% fall, over the last year AMGEN has showed a +42.09% increase.
What is AMGEN market cap?▼
Today AMGEN has the market capitalization of 183.06B
When is the next AMGEN earnings date?▼
AMGEN is going to release the next earnings report on November 03, 2026.
What were AMGEN earnings last quarter?▼
AMG.MU earnings for the last quarter are 5.45 EUR per share, whereas the estimation was 4.87 EUR resulting in a +11.97% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is AMGEN revenue for the last year?▼
AMGEN revenue for the last year amounts to 31.87B EUR.
What is AMGEN net income for the last year?▼
AMG.MU net income for the last year is 6.69B EUR.
Does AMGEN pay dividends?▼
Yes, AMG.MU dividends are paid quarterly. The last dividend per share was 2.19 EUR. As of today, Dividend Yield (FWD)% is 2.42%.
How many employees does AMGEN have?▼
As of September 09, 2026, the company has 31,500 employees.
In which sector is AMGEN located?▼
AMGEN operates in the Health & Wellness sector.
When did AMGEN complete a stock split?▼
AMGEN has not had any recent stock splits.
Where is AMGEN headquartered?▼
AMGEN is headquartered in THOUSAND OAKS, United States.